Drug ID:   | NPD9684 |
Drug Name:   | |
Molecular Formula:   | C9H23NO7P2 |
Canonical SMILES:   | CCCCCN(CCC(P(=O)(O)O)(P(=O)(O)[O-])O)C |
Standard InCHI:   | InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)/p-1 |
Standard InCHIKey:   | MPBVHIBUJCELCL-UHFFFAOYSA-M |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Remote Similarity | 0.6275 | NPC81384 |
Remote Similarity | 0.6 | NPC79954 |
Remote Similarity | 0.6 | NPC314567 |
TTD   | DNCL003771 |
DrugBank   | |
ChEMBL   | |
IUPHAR/BPS   | |
PharmaGKB   | |
KEGG Drug   | |
PubChem CID   | 23663991 |
ChEBI   | |
CAS Number   |
Molecular Weight   | 318.09 |
ALogP   | -2.7827 |
MLogP   | 1.35 |
XLogP   | -2.108 |
HDA   | 8 |
HBD   | 4 |
Rotatable Bonds   | 16 |
TPSA   | 160.98 |
RO5 Violation   | 0 |